Imunexus - IPO for innovative biotechnology company
¿Quieres ganar un trabajo como este?
Este cliente recibió 240 diseños de logo de 47 diseñadores. Eligieron este diseño de logo de logo_s como el diseño ganador.
Únete gratis Encuentra trabajos de diseño- Garantía
Resumen de Diseño de Logo
We need a logo design for a new biotechnology company based in Melbourne, Australia. The company is called Imunexus, and is preparing for an initial public offering (IPO) on the Australian Stock Exchange (ASX). Imunexus offers a 'plug-and-play' technology platform for rapid development of 'biobetters', the rough equivalent of 'super-generic' drugs. Biobetters are improved biological drugs (e.g. antibodies) that are similar to the original antibody, but have substantive structural modifications that enhance the efficacy of the drug. Biobetters work much better than simple 'biosimilars' which are closer copies of the original drug, and do not work any better than the original drug. Please refer to the attached brief summary, in particular logo design concepts on page 3.
Actualizaciones
Project Deadline Extended
Reason: Need to get consensus amongst Board.
Added Tuesday, June 2, 2015
Objetivo del mercado(s)
Biotechnology investors - high net worths, sophisticated, and retail
Tipo de industria / entidad
Biotechnology
Texto del logo
Imunexus
Estilos de logo de interés
Logo pictórico / combinado
Un objeto del mundo real (texto opcional)
Logo con personaje
Logo con ilustración o personaje
Mira y siente
Cada control deslizante ilustra las características de la marca del cliente y el estilo que debe comunicar el diseño de tu logotipo.
Elegante
Atrevido
Juguetón
Serio
Tradicional
Moderno
Atractivo
Profesional
Femenino
Masculino
Vistoso
Conservador
Económico
De Alta Gama
Requisitos
Debes tener
- Please see page 3 of the attached brief. NOTE: We are not committed to the boomerang concept; it is one suggestion. Other concepts are welcome.
Agradable de tener
- Please see page 3 of the attached brief. Innovation, next-generation, breakthrough, combination, nexus.
No debería tener
- Please see page 3 of the attached brief